NASDAQ: BCDA - BioCardia, Inc.

Lønnsomhet i seks måneder: -6.81%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan BioCardia, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet BioCardia, Inc.

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease.

flere detaljer
The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2008-03-14
ISIN US09060U5074
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.biocardia.com
Цена ао 2.57
Prisendring per dag: 0% (2.6)
Prisendring per uke: +2.36% (2.54)
Prisendring per måned: -4.41% (2.72)
Prisendring over 3 måneder: +24.4% (2.09)
Prisendring over seks måneder: -6.81% (2.79)
Prisendring per år: +573.05% (0.3863)
Prisendring over 3 år: +24.4% (2.09)
Prisendring over 5 år: -40.23% (4.35)
Prisendring over 10 år: 0% (2.6)
Prisendring siden begynnelsen av året: +30% (2)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 28.86 1
P/BV -8.59 0
P/E 0 0
EV/EBITDA -1.24 0
Total: 3.38

Effektivitet

Navn Betydning Karakter
ROA, % -387.38 0
ROE, % 721.83 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 1.43

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.1171 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -32.82 0
Lønnsomhet Ebitda, % -17.43 0
Lønnsomhet EPS, % 211.59 10
Total: 2.2
Flere detaljer

Institusjoner Volum Dele, %
CM Management, LLC 700000 14.44
Vanguard Group Inc 650763 13.42
Geode Capital Management, LLC 159648 3.29
Renaissance Technologies, LLC 88300 1.82
Family Management Corporation 77500 1.6
Susquehanna International Group, LLP 65426 1.35
Blackrock Inc. 42767 0.88
Virtu Financial LLC 41348 0.85
Citadel Advisors Llc 33629 0.69
Brown Advisory Inc. 33085 0.68



Veileder Stillingstittel Betaling Fødselsår
Dr. Peter A. Altman Ph.D. CEO, President & Director 515.51k 1967 (58 år)
Mr. David McClung Chief Financial Officer 370.86k 1963 (62 år)
Mr. Edward M. Gillis Senior Vice President of Devices 263.1k 1962 (63 år)

Adresse: United States, Sunnyvale. CA, 320 Soquel Way - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.biocardia.com